Bacterial meningitis is a global public health concern, with several responsible etiologic
agents that vary by age group and geographical area. The aim of this systematic review and …

Background Invasive meningococcal disease (IMD), caused by Neisseria meningitidis,
leads to significant morbidity and mortality worldwide. This review aimed to establish the …

This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) for use of meningococcal vaccines in the United States …

Background The meningococcal group B vaccine 4CMenB is a new, recombinant protein-
based vaccine that is licensed to protect against invasive group B meningococcal disease …

The control of meningitis, meningococcemia and other infections caused by Neisseria
meningitidis is a significant global health challenge. Substantial progress has occurred in …

Introduction: Neisseria meningitidis serogroup B (MenB) is the most common cause of
bacterial meningitis in many industrialized countries and occurs at any age. The highest …

We reviewed university-based outbreaks of meningococcal disease caused by serogroup B
and vaccination responses in the United States in the years following serogroup B …

Objectives 4CMenB is a broadly protective vaccine against invasive meningococcal
capsular group B disease (MenB IMD). Licensed worldwide based on immunogenicity and …

Colonization of the human nasopharyngeal tract by the bacterium Neisseria meningitidis is
usually asymptomatic, but life-threatening meningococcal disease with a clinical …

Neisseria meningitidis is a major cause of meningitis and septicemia with cases, outbreaks,
and epidemics reported globally in industrialized and non-industrialized countries. N …